GSK’s Phase II, Single-Arm Trial For Jemperli In Rectal Cancer Gets Panel Nod

 
• By Sue Sutter
Plane taking off
GSK's plan for accelerated approval based on single-arm studies was cleared for takeoff by ODAC. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers